← Back to Search

Advance Care Planning for Cancer

N/A
Waitlist Available
Led By Yael Schenker, MD, MPH
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years of age or older
Does not speak English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, up to 5 years
Awards & highlights

Study Summary

This trial will help identify the best way to help patients with advanced cancer plan for their care.

Who is the study for?
This trial is for adults with advanced cancer who are expected to continue care at a participating clinic, can participate in either web-based or facilitated advance care planning (ACP), and have someone involved in their care. Excluded are those without phone access, unable to consent, with blood cancers, or unable to complete the baseline interview.Check my eligibility
What is being tested?
The study aims to find out which ACP method works best for patients with advanced cancer and their caregivers: an in-person guided discussion or using a web-based program. It will also look at costs and how these methods affect end-of-life healthcare use.See study design
What are the potential side effects?
Since this trial involves non-medical interventions like discussions about future medical care preferences rather than drugs or medical procedures, traditional physical side effects are not applicable.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I do not speak English.
Select...
I can take care of myself and am up and about more than half of my waking hours.
Select...
I am 18 years old or older.
Select...
I am the main person taking care of the patient and can participate in the study.
Select...
I plan to continue my cancer treatment at a participating clinic.
Select...
I am willing to join a program online or in person.
Select...
I cannot complete the initial interview.
Select...
I have a solid tumor.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Advance care planning engagement
Secondary outcome measures
Receipt of goal-concordant end-of-life care - patient wishes followed
Receipt of goal-concordant end-of-life care - place of death
advance care planning discussions with caregivers
+7 more
Other outcome measures
Healthcare utilization at end of life - ED visits
Healthcare utilization at end of life - ICU
Healthcare utilization at end of life - chemotherapy
+5 more

Trial Design

2Treatment groups
Active Control
Group I: Facilitated advance care planning (in-person or telephonic)Active Control1 Intervention
Patients randomized to this arm will participate in in-person or telephonic facilitated advance care planning (ACP) discussions using the Respecting Choices model.
Group II: Web-based advance care planningActive Control1 Intervention
Patients randomized to this arm will participate in web-based ACP via the PREPARE website.

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,712 Previous Clinical Trials
16,345,711 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,603 Previous Clinical Trials
40,912,575 Total Patients Enrolled
Yael Schenker, MD, MPHPrincipal InvestigatorUniversity of Pittsburgh

Media Library

Facilitated advance care planning (in-person or telephonic) Clinical Trial Eligibility Overview. Trial Name: NCT03824158 — N/A
Cancer Research Study Groups: Facilitated advance care planning (in-person or telephonic), Web-based advance care planning
Cancer Clinical Trial 2023: Facilitated advance care planning (in-person or telephonic) Highlights & Side Effects. Trial Name: NCT03824158 — N/A
Facilitated advance care planning (in-person or telephonic) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03824158 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there currently any opportunities to participate in this research endeavor?

"According to clinicaltrials.gov, this research endeavor is not recruiting patients at the moment. It was inaugurated on August 1st 2019 and most recently updated on April 11th 2022; however, there are 502 different trials that currently require participants."

Answered by AI
~125 spots leftby Mar 2025